Showing results (1201-1210 of 1,437) with videos related to

Sort By:
Pageof 144
The Journal of Clinical Investigation|December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integrationChristopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
JCI Insight|April 14, 2017
Efficacy of ALK5 inhibition in myelofibrosisLanzhu Yue, Matthias Bartenstein, Wanke Zhao, et al.
Cancer Cell|February 23, 2010
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutaratePatrick S Ward, Jay Patel, David R Wise, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2023
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is TargetableTamara Codilupi, Jakub Szybinski, Stefanie Arunasalam, et al.
Leukemia|January 5, 2024
FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemiaPamela J Sung, Murugan Selvam, Simone S Riedel, et al.
The New England Journal of Medicine|September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaAlfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
Frontiers in Immunology|September 8, 2025
Multiplex engineering using microRNA-mediated gene silencing in CAR T cellsGiulia Golinelli, John Scholler, Audrey Roussel-Gervais, et al.
Blood|January 13, 2016
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groupsMarlise R Luskin, Ju-Whei Lee, Hugo F Fernandez, et al.
Science Translational Medicine|May 20, 2011
Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activityKeli L Hippen, Sarah C Merkel, Dawn K Schirm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedsideCheryl Lai-Lai Chiang, Lana E Kandalaft, Janos Tanyi, et al.
Pageof 144